Retatrutide (LY3437943) is an investigational peptide studied for interaction with three receptor pathways: GLP-1, GIP, and glucagon receptors
Frontiers in Immunology , 11 , 616367 Baumann, T., Dunkel, A., Schmid, C., Schmitt, S., Hiltensperger, M., Lohr, K., Laketa, V., Donakonda, S., Ahting, U., Lorenz-Depiereux, B., Heil, J
And a Medicaid plan that is administered through UHC has Trulicity listed as a Tier 1 drug with $0 copay, although a prior authorization is required
Compared with that, GLP-1s do have some effect on insulin, but it seems to be a lower amount for a more extended period of time
When Might GLP-1s Be the Faster Option
, : - , , , , , - GLP-1